Non-CME/CE Industry
Cardiology
Join our experts for an insightful discussion of clinical evidence and guideline-informed approaches to LDL-C lowering, and explore strategies to reduce the risk of major adverse cardiovascular events in patients at high CV risk without prior MI or stroke. This presentation will include discussion of a treatment option.
Amgen Inc.